Evidence map›Paper›PMID 12438450›Full record

ArticleThe Journal of clinical investigation2002

Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.

Junwei Yang, Ryan W Shultz, Wendy M Mars, Rodney E Wegner, Yingjian Li, Chunsun Dai, Kari Nejak, Youhua Liu

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 227 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Twist1 in Infiltrating Macrophages Attenuates Kidney FibrosisJournal of the American Society of Nephrology : JASN · 2019
    Article
  15. Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Junwei YangDivision of Cellular and Molecular Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.
Ryan W Shultz
Wendy M Mars
Rodney E Wegner
Yingjian Li
Chunsun Dai
Kari Nejak
Youhua Liu
University of Pittsburgh · USNorthrop Grumman (United States) · US

Funding

HGF Gene Therapy for Chronic Renal FibrosisR01DK061408 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LIU, YOUHUA · 2002 to 2009
$1.9M
HGF RECEPTOR GENE REGULATION AND RENAL GROWTHR01DK054922 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LIU, YOUHUA · 1998 to 2006
$1.5M
HGF RECEPTOR GENE REGULATION AND RENAL GROWTHK02DK002611 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LIU, YOUHUA · 1999 to 2003
$394k
NIDDK NIH HHS DK-02611NIDDK NIH HHS DK-54922NIDDK NIH HHS DK-61408NIDDK NIH HHS R01 DK054922NIDDK NIH HHS R01 DK061408
6 · The paper itself

Abstract

Tissue-type plasminogen activator (tPA) is one of the major components in the matrix proteolytic network whose role in the pathogenesis of renal interstitial fibrosis remains largely unknown. Here, we demonstrate that ablation of tPA attenuated renal interstitial fibrotic lesions in obstructive nephropathy. Mice lacking tPA developed less morphological injury and displayed a reduced deposition of interstitial collagen III and fibronectin as well as total tissue collagen in the kidneys after sustained ureteral obstruction, when compared with their wild-type counterparts. Deficiency of tPA selectively blocked tubular epithelial-to-myofibroblast transition (EMT), but did not affect myofibroblastic activation from interstitial fibroblasts. A marked decrease in matrix metalloproteinase-9 (MMP-9) induction was found in the obstructed kidneys of tPA(-/-) mice, which led to a dramatic preservation of the structural and functional integrity of tubular basement membrane (TBM). In vitro, tPA induced MMP-9 gene expression and protein secretion in renal interstitial fibroblasts. Thus, increased tPA is detrimental in renal interstitial fibrogenesis through a cascade of events that lead to MMP-9 induction, TBM destruction, and promotion of EMT. Our findings establish a crucial and definite importance of EMT in the pathogenesis of renal interstitial fibrosis at the whole-animal level.

Indexed as

AnimalsBasement MembraneEpitheliumFibroblastsFibrosisKidney DiseasesKidney TubulesMaleMatrix Metalloproteinase 9MiceMice, KnockoutTissue Plasminogen ActivatorMatrix Metalloproteinase 9Tissue Plasminogen Activator

Identifiers

PMID12438450
PMCPMC151817
OpenAlexW2028323686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.